Preclinical targeting of NF-κB and FLT3 pathways in AML cells
暂无分享,去创建一个
V. Imbert | J. Peyron | M. Dréano | N. Sirvent | E. Griessinger | N. Çuburu | C. Dageville | C. Frelin | M. Hummelsberger | Emmanuel Griessinger | Nicolas Çuburu | Nicolas Sirvent | Michel Dreano